Global health

Hain Celestial to Showcase Garden Veggie™ Flavor Burst™ Tortilla Chips & Earth's Best® Smoothie Benefits Innovation at Natural Products Expo West 2024

Retrieved on: 
Wednesday, March 6, 2024
Cheese, Snack, Mineral, Growth, BFY, Quality, Hain Celestial Group, Global health, Food, Vegetable, Immunity, Anaheim Convention Center, HAIN, Taste

HOBOKEN, N.J., March 6, 2024 /PRNewswire/ -- The Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you (BFY) brands, announced today that it will showcase several breakthrough innovations across its global portfolio at Expo West 2024 held March 12-16 at the Anaheim Convention Center. Located in Booth #404, Hain will be sampling Garden Veggie™ Flavor Burst™ Tortilla Chips, as well as highlighting Earth's Best® Organic Support Smoothies and new sustainable packaging solutions from the Ella's Kitchen® & Celestial Seasonings® brands.

Key Points: 
  • Located in Booth #404, Hain will be sampling Garden Veggie™ Flavor Burst™ Tortilla Chips, as well as highlighting Earth's Best® Organic Support Smoothies and new sustainable packaging solutions from the Ella's Kitchen® & Celestial Seasonings® brands.
  • "We'll also be highlighting leading brands from our global portfolio that are available in more than 75 countries worldwide.
  • Garden Veggie ™ Flavor Burst™ Tortilla Chips - Garden Veggie Snacks, the trailblazer in better-for-you snacking, recently launched its first better-for-you flavored tortilla chip.
  • Additionally, Hain will be featuring innovation from The Greek Gods® yogurt, Celestial Seasonings® teas, Alba Botanica® sun care and Live Clean® personal care.

Puritan's Pride Steadily Expands Its Global Influence, Securing a Leading Position Among Nutritional Brands

Retrieved on: 
Wednesday, March 6, 2024
Well, International, Multimedia, Mineral, Cardiovascular disease, Vitamin, Pride, Sale, Lycopene, Global health, Conference, Health, Lutein, Puritans, Coenzyme Q10, Beauty, Dietary supplement

Throughout the conference, experts analyzed the current state of cardiovascular research and made predictions for the future of cardiovascular disease.

Key Points: 
  • Throughout the conference, experts analyzed the current state of cardiovascular research and made predictions for the future of cardiovascular disease.
  • Puritan's Pride™, a global brand, was honored with the Cardiovascular Health Outstanding Contribution Award during the event.
  • It has established itself as one of the leading nutritional supplement brands, boasting a customer base of more than six million satisfied individuals.
  • Puritan's Pride™ is a leading health supplement company established in 1973 in Long Island, New York.

Body Vision Medical Announces Successful Validation of LungVision™ System with Fujifilm's Range of Surgical C-arms

Retrieved on: 
Tuesday, March 5, 2024
Marketing, Red Dot, Artificial intelligence, Physician, Biopsy, Thought, Fluoroscopy, Global health, Fujifilm, Medical imaging, Patient, Survival, Lung cancer, Diagnosis

CAMPBELL, Calif., March 5, 2024 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today the successful validation of Body Vision's LungVision™ system with FUJIFILM Healthcare Americas Corporation's Persona line of C-arms and FDR Cross two-in-one fluoroscopy C-arm and portable digital radiography solution.

Key Points: 
  • CAMPBELL, Calif., March 5, 2024 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today the successful validation of Body Vision's LungVision™ system with FUJIFILM Healthcare Americas Corporation's Persona line of C-arms and FDR Cross two-in-one fluoroscopy C-arm and portable digital radiography solution.
  • Body Vision Medical's LungVision™ system uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative CT scans.
  • "This validation further demonstrates the power of an AI-driven imaging platform like LungVision™ that enables physicians to agnostically leverage our image-guided navigation and real-time imaging with the bronchoscopy platform and C-arm of their choice," said David Webster, CEO of Body Vision Medical.
  • "We're elated to see the successful validation of our C-arm platforms with Body Vision's leading LungVision™ system to synergistically provide the visualization needed by bronchoscopists during navigation bronchoscopy".

Clinical Microbiomics adds World-Leading Expertise in Long-Read DNA & RNA Sequencing Technologies with Acquisition of DNASense ApS

Retrieved on: 
Friday, March 1, 2024
Acquisition, Soil, QMS, Animal, CCO, Global health, Metabolomics, RNA, Human, Environment, Quality management system, CSO, Agriculture, Laboratory, Research, DNA, Water, Partnership, Antibiotics

The acquisition expands Clinical Microbiomics' expertise and offering for new segments such as agriculture, industrial, and environmental ecosystems, and it adds cutting-edge long- read DNA- and RNA sequencing technologies to the extensive portfolio of multi-omics technologies for the microbiome field.

Key Points: 
  • The acquisition expands Clinical Microbiomics' expertise and offering for new segments such as agriculture, industrial, and environmental ecosystems, and it adds cutting-edge long- read DNA- and RNA sequencing technologies to the extensive portfolio of multi-omics technologies for the microbiome field.
  • H. Bjørn Nielsen, CSO of Clinical Microbiomics, "DNASense is a first mover in applying long-read technology broadly across microbiome research and industrial applications.
  • Mads Søndergaard, CEO of DNASense, comments on the synergies: "Joining Clinical Microbiomics is a pivotal moment for DNASense.
  • The DNASense acquisition facilitates expansion into new applications of microbiome science to better understand diverse biological systems and ecological dynamics.

Nalu Bio Adds Top CPG Talent, Dondeena Bradley, to Board to Drive Adoption of No-High, Chemistry-Derived Cannabinoids for Health and Wellness

Retrieved on: 
Thursday, February 29, 2024
Well, SAN, Mental health, Woman, Fortune 500, Caregiver, Nutrition, Research, Health, Vitamin, Female, CPG, Global health, Food science, Cannabinoid, Harvard Business Review, Empathy, McKinsey & Company, Wellness, Health equity, Science, Public, Management

SAN FRANCISCO, Feb. 29, 2024 /PRNewswire/ -- Nalu Bio, a biotech company that is expanding health and wellness solutions through the development of no-high, chemistry-derived cannabinoid CPG ingredients, products, and therapeutic applications, proudly announces the appointment of Dondeena Bradley to its board of directors. With a distinguished career guiding health and wellness strategy, research and development, and wellbeing and nutrition-based innovations for the top global CPG companies, Dondeena brings invaluable expertise to drive an industry shift comparable to the introduction of vitamins 70 years ago—all while while closing the women's wellness gap—a $1 trillion opportunity to improve lives and economies globally.1

Key Points: 
  • "Dondeena brings valuable insights into CPG solution development and the pivotal stage for global health and wellness leaders' adoption of cannabinoids, making her an invaluable addition to our board," stated Caitlyn Krebs, Co-founder and CEO of Nalu Bio.
  • Dondeena joins Nalu Bio as the third female board member, including co-founders Caitlyn Krebs (CEO) and Phyllis Whiteley (Chairman of the Board), who collectively bring decades of pharmaceutical and healthcare experience that drive impact.
  • With Dondeena Bradley on its board, Nalu Bio is poised to lead the way in reshaping the future of consumer health and wellness.
  • As the first company to offer AI-powered combinations of cannabinoids and bioactives, Nalu Bio continues to drive advancements designed to impact global CPG companies' innovation pipelines.

Bill Gates Receives the Prestigious KISS Humanitarian Award 2023

Retrieved on: 
Wednesday, February 28, 2024
Virtue, KIIT, Grameen Bank, FXB International, Education, Work, Global health, Hope, Sacredness, KIMS, Social justice, Climate change, Hanseo University, Republic, Organization, Nobel Peace Prize, Heart, KISS, Bill, Supreme court, Nobel, Microsoft, Student

BHUBANESWAR, India, Feb. 28, 2024 /PRNewswire/ -- Leading global philanthropist, Mr. Bill Gates, co-founder of Microsoft and co-chair of the Bill & Melinda Gates Foundation was honored with the KISS Humanitarian Award 2023 in a significant recognition of his philanthropic work.

Key Points: 
  • BHUBANESWAR, India, Feb. 28, 2024 /PRNewswire/ -- Leading global philanthropist, Mr. Bill Gates, co-founder of Microsoft and co-chair of the Bill & Melinda Gates Foundation was honored with the KISS Humanitarian Award 2023 in a significant recognition of his philanthropic work.
  • The award ceremony featured virtual participation from the staff and students of KIIT and KISS, along with alumni.
  • Prof. Achyuta Samanta, Founder of KIIT, KISS & KIMS said, "Awarding Bill Gates with the KISS Humanitarian Award not only honors his exceptional contributions but also elevates the prestige of this recognition.
  • Initiated in 2008 by Prof. Achyuta Samanta, the KISS Humanitarian Award is the highest honour of KIIT and KISS dedicated to recognizing individuals and organizations that embody the spirit of humanitarian work worldwide.

Bill Gates Receives the Prestigious KISS Humanitarian Award 2023

Retrieved on: 
Wednesday, February 28, 2024
Virtue, KIIT, Grameen Bank, FXB International, Education, Work, Global health, Hope, Sacredness, KIMS, Social justice, Climate change, Hanseo University, Republic, Organization, Nobel Peace Prize, Heart, KISS, Bill, Supreme court, Nobel, Microsoft, Student

BHUBANESWAR, India, Feb. 28, 2024 /PRNewswire/ -- Leading global philanthropist, Mr. Bill Gates, co-founder of Microsoft and co-chair of the Bill & Melinda Gates Foundation was honored with the KISS Humanitarian Award 2023 in a significant recognition of his philanthropic work.

Key Points: 
  • BHUBANESWAR, India, Feb. 28, 2024 /PRNewswire/ -- Leading global philanthropist, Mr. Bill Gates, co-founder of Microsoft and co-chair of the Bill & Melinda Gates Foundation was honored with the KISS Humanitarian Award 2023 in a significant recognition of his philanthropic work.
  • The award ceremony featured virtual participation from the staff and students of KIIT and KISS, along with alumni.
  • Prof. Achyuta Samanta, Founder of KIIT, KISS & KIMS said, "Awarding Bill Gates with the KISS Humanitarian Award not only honors his exceptional contributions but also elevates the prestige of this recognition.
  • Initiated in 2008 by Prof. Achyuta Samanta, the KISS Humanitarian Award is the highest honour of KIIT and KISS dedicated to recognizing individuals and organizations that embody the spirit of humanitarian work worldwide.

Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free Zones

Retrieved on: 
Tuesday, February 27, 2024
DNA, MCIT, Ginkgo Bioworks, Artificial intelligence, TGS, Biophysical environment, Growth, Airport, Global health, QFZ, HE, COVID-19, DVC, CDC, State, Biology, Information technology, Epidemiology, Communication, Travel, Partnership, Vaccine

DOHA, Qatar, Feb. 27, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, has announced today the signing of an agreement with Qatar Free Zones Authority (QFZ) and Doha Venture Capital (DVC) to build the first Center for Unified Biosecurity Excellence in Doha (CUBE-D) within Qatar Free Zones. The signing took place alongside QFZ's and DVC's participation in the Web Summit Qatar, in a ceremony attended by HE. Dr. Ahmad Al-Sayed, Minister of State and Chairman of QFZ/DVC, HE. Mohammed bin Ali Al Mannai, Minister of Communications and Information Technology (MCIT) and Vice Chairman of QFZ/DVC, and Matthew McKnight, General Manager for Biosecurity, Ginkgo Bioworks, along with executives from the ministry and the three signing entities.  

Key Points: 
  • The signing took place alongside QFZ's and DVC's participation in the Web Summit Qatar, in a ceremony attended by HE.
  • CUBE-D's advanced platform is expected to serve as a nucleus for global pathogen monitoring efforts and be a key hub in Ginkgo's bioradar network.
  • I am proud of Ginkgo's ability to technically and socially synthesize this global immune system, one node and hub at a time.
  • Matthew McKnight, General Manager of Biosecurity at Ginkgo Bioworks: "CUBE-D represents the next generation of biosecurity infrastructure.

Doceree celebrates 100% Y-o-Y Growth, Credits Success to 3x Surge in Trigger-Based Campaigns

Retrieved on: 
Tuesday, February 27, 2024
Adtech (company), HCP, Trigger, USD, Artificial intelligence, AI, POC, HIMSS, Marketing, Growth, Global health, ChatGPT, Patent, Ecosystem, MEA, Privacy, Sales

Highlighting its expansive reach, Doceree engaged with over 5 million HCPs across 25+ markets through more than 4,000 campaigns in 2023.

Key Points: 
  • Highlighting its expansive reach, Doceree engaged with over 5 million HCPs across 25+ markets through more than 4,000 campaigns in 2023.
  • To further bolster relationships and foster knowledge sharing among partners, Doceree unveiled The Next Marketing Lab during Digital Pharma East 2023.
  • As a global organization, Doceree underscored its commitment to Diversity, Equity, and Inclusion (DE&I) by implementing a comprehensive global initiative across its offices.
  • Currently, Doceree is actively seeking to enhance its talent pool, offering over 50 new employment opportunities worldwide.

Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO

Retrieved on: 
Tuesday, February 27, 2024
Medicine, Vaccine, Weapon, Disease, Micrometre, GAVI, Global health, Pharmaceutical industry

ATLANTA, Feb. 27, 2024 /PRNewswire/ -- Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced the appointment of global public health pioneer, Dr. Seth Berkley, as scientific advisor to the CEO. In this capacity, Dr. Berkley will guide the company's strategic manufacturing and supply chain efforts, as well as the go-to-market strategy including quality, distribution and pricing. 

Key Points: 
  • In this capacity, Dr. Berkley will guide the company's strategic manufacturing and supply chain efforts, as well as the go-to-market strategy including quality, distribution and pricing.
  • "It's time our current way of delivering injectable pharmaceuticals was disrupted," said Dr. Seth Berkley.
  • "As I continue my work championing equitable access to vaccines and improving the way the world prevents and responds to disease, I am thrilled to take an active role in improving global health as a strategic technical advisor to Micron Biomedical."
  • Last year, Micron Biomedical announced it is working to build one of the first mass manufacturing facilities of needle free vaccines in the world.